black box warning glp 1 for agonists Pharmacovigilance Assessment of Compounded GLP-1 Receptor Agonists: Insights From the FDA Adverse Event Reporting System Montelukast Warning Upgraded | MedPage
Description
Why New Orleans Patients Choose Compounded Semaglutide Over Brand-Name Ozempic Ozempic is FDA-approved as a diabetes medication, but many weight loss patients seek alternatives due to cost, availability, or insurance coverage limitations
White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F: EXAMINE Investigators
At this time, we are unable to offer our GLP-1 programs in New Mexico, Mississippi, and Louisiana
Its a perplexing situation that can lead to feelings of disappointment, confusion, and even discouragement
Final Thoughts If youre reading this and using statinsor planning toand youre considering GLP-1 therapy (or already on it), this research is a reminder: medicine is always evolving
In 2026, the options have expanded beyond simple injections to include highly effective oral tablets
